Taiwanese firm teams up with U.S. to develop coronavirus vaccine

02/17/2020 04:36 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, Feb. 17 (CNA) Taiwan-based Medigen Vaccine Biologics Corp. (MVC) announced Monday that it has teamed up with the U.S. National Institutes of Health (NIH) to develop a vaccine against COVID-19 coronavirus.


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.